The Latest Breaking News from Valneva

New Valneva Covid-19 vaccine approved in the UK

The approval comes as rising cases have a "major impact" on the NHS

Manchester Evening News · Apr 14, 2022

New Covid vaccine approved for use in the UK

It comes as the number of deaths continues to rise

Wales Online · Apr 14, 2022

Valneva vaccine: Sixth Covid jab approved by UK regulator

Storage temperature ‘similar to that of a domestic fridge’, government scientific advisor says

The Independent UK · Apr 14, 2022

The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga · Mar 11, 2022

Read Why Valneva's Stock Gained 7% Today

Valneva SE (NASDAQ:VALN) completed the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate, VLA1553. Valneva posted topline results from the phase 3 trial in August last year. The primary endpoint result is mainly unchanged from that data drop.  The removal of two subjects from the analysis increased the proportion of participants with protective…

Benzinga · Mar 8, 2022

The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Mar 8, 2022

Valneva Receives Emergency Use Authorization from Bahrain

Bahrain has granted emergency use authorization to the COVID-19 vaccine developed by France's Valneva (VLS.PA), the company said in a statement on Tuesday. Valneva expects to deliver the first shipments of its VLA2001 vaccine to the kingdom at the end of March, after it signed an advance purchase deal for…

Asharq Al-Awsat · Mar 1, 2022

Valneva Expects European Recommendation On COVID-19 Shot By March End

Valneva SE (NASDAQ: VALN) expects to start delivering its vaccine in Europe soon after it is recommended for conditional approval by the end of March.

Benzinga · Feb 25, 2022

Valneva Secures £20M From Scottish Enterprise For Vaccine Development

Valneva SE (NASDAQ: VALN) has been 

Benzinga · Feb 22, 2022

West Lothian covid vaccine manufacturer awarded £20million to develop jabs

Valneva has been awarded the massive cash injection from the Scottish Government

Daily Record · Feb 21, 2022